Rankings
▼
Calendar
SNDX Q4 2016 Earnings — Syndax Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena
SNDX
Syndax Pharmaceuticals, Inc.
$2B
Q4 2016 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$305,000
Gross Profit
$305,000
100.0% margin
Operating Income
-$11M
-3652.8% margin
Net Income
-$11M
-3545.9% margin
EPS (Diluted)
$-0.59
QoQ Revenue Growth
+0.0%
Cash Flow
Operating Cash Flow
-$10M
Free Cash Flow
-$10M
Stock-Based Comp.
$947,000
Balance Sheet
Total Assets
$109M
Total Liabilities
$25M
Stockholders' Equity
$84M
Cash & Equivalents
$24M
← FY 2016
All Quarters
Q1 2017 →
